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Abstract: The effectiveness of two social support
strategies designed to lower hypertensive patients'
blood pressure were compared to each other and to a
control group (N = 63) receiving routine care in a
randomized clinical trial extending over a period of
two years. Group 1 (N = 99) received visits and had
family members actively participate in their care
through home blood pressure monitoring; Group 2 (N
= 56) received home visits from nurses and pharma-
cists. All groups were predominantly Black. After the
first year of the trial, the proportion of patients with
uncontrolled diastolic blood pressure (-95mm Hg)
had declined significantly for all three groups; no
group showed a statistically significant advantage.
However, during the last six months of the second
Cardiovascular disease mortality in the United States
has recently shown a marked decline. Although current
hypertension control efforts are credited with part of the
reduction in death rates,' high blood pressure remains one of
the most common chronic conditions in the US today,
accounting for the largest percentage of visits to internists in
the country.2 Nearly 60 million individuals, or one-fourth of
the adult population, are affected when borderline and
controlled hypertensives are also counted.3
Studies have shown that both mild and moderate-to-
severe hypertension can be effectively treated,45 and that
elevated blood pressure levels and associated pathology can
be reduced as a result.6 These benefits, however, are obvi-
ously mediated by patients' ability to comply with their
medical regimens. Although there have been recent im-
provements in the nation's awareness of the magnitude of
untreated or poorly-controlled hypertension, as well as in
the detection of previously uncontrolled hypertensives, lev-
els of compliance with blood pressure medications remain a
problem.7
Along with the increase in knowledge about hyperten-
sion has come a better understanding of the characteristics
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year (after visiting had ended), both Groups I and 2
demonstfated clear superiority in DBP control over
Group 3, achieving borderline statistical significance
(p = .07) when multivariable analysis was performed
to control for potential confounders. Supplementing
routine care with periodic home visits produced an
additional 21 per cent of patients with well-controlled
DBP, while involving family members plus visits pro-
duced a 17 per cent improvement in the percentage of
patients with DBP < 95mm Hg. However, neither
support strategy was clearly more effective than the
other over time. The efficacy of the interventions is
discussed with respect to cost and feasibility of imple-
mentation. (Am J Public Health 1982; 72:1146-1154.)
of persons who have difficulty adhering to their medical
regimens.8-'0 As a result of a targeted effort by the National
High Blood Pressure's Education Research Program," the
effectiveness of several patient education strategies for help-
ing hypertensive patients improve their compliance has been
demonstrated. 12-14 While findings from diverse populations in
different settings using a variety of outcome measures are
inevitably mixed, studies generally indicate the efficacy in
controlling blood pressure of such behavioral methods as:
active participation of patients in their own care,'5 '6 in-
volvement of patients' families'7 in their ongoing manage-
ment,'8,'9 and increased supervision through home visits by
health professionals.'2,20,2'
While several types of educational, behavioral, and
organizational strategies involving the provision of support
by friends, family members, and home visitors have been
found effective for improving hypertensive patients' health-
related outcomes,22 either the benefits have disappeared
once the intervention is withdrawn23 or they are impractical
to implement on a long-term basis for all those who can
benefit. Thus patients' monitoring of their own blood pres-
sures was found to be ineffective without the continuous
reinforcement of home visitors;'5 similarly, the benefits of
home visiting without family involvement was also found to
wane over time.2' Furthermore, while the efficacy of home
blood pressure monitoring, family involvement, and profes-
sional home visiting have been examined singly, or even in a
paired design,'2'24 active family participation in both the
blood pressure measurement process and during the health
professionals' home visits has not, to our knowledge, been
studied previously. Whether supportive family involvement
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in hypertensive patients' efforts to actively participate in
their own care, when these efforts are periodically reinforced
by visiting nurses or pharmacists, is an effective blood
pressure control strategy over a relatively long period of
time is the central question examined in the research de-
scribed in this paper.
Project Objectives
The purpose of this paper is to:
* describe the protocol of the Hypertension Education
Project (HEP);
* characterize HEP patients and their families at the
time they entered the study; and
* report on the effect of two behavioral change strate-
gies for controlling blood pressures of already-diagnosed
hypertensive patients over a two-year period.
The two compliance strategies compared to each other,
as well as to standard medical care, within the framework of
a randomized controlled trial are: 1) active involvement of
both patients and selected family members in the blood
pressure monitoring process, and 2) supportive reinforce-
ment of patients through periodic visits to their homes by
health professionals.
Materials and Methods
Medical criteria for eligibility in HEP included: a diag-
nosis of essential hypertension, a strong likelihood of being
ambulatory for the coming two years, and freedom from
significant mental illness or alcoholism. In addition, patients
had to be on a hypertensive medication which, in the
previous two months, had been initiated, altered in some
manner, or restarted after a drug-free hiatus. These criteria
were used to exclude individuals not expected to show
significant enough blood pressure variability during the
course of the HEP trials to suggest they either needed, or
could benefit from, the type of patient education strategies
being tested. Most patients found ineligible on clinical
grounds were either not on anti-hypertensive medications at
the time they were seen at clinic or had had no medication
change in the preceding two months.
Patients came from a 435-bed community hospital's
nurse-run hypertension clinic and from four internal medi-
cine subspecialty clinics and a family practice clinic of a 480-
bed university teaching hospital. Between October 1975, and
September 1976, all charts of hypertensive patients appear-
ing to meet the above criteria and scheduled for an appoint-
ment in one of these six clinics were flagged. Those patients
keeping their appointments were referred to HEP interview-
ers.
Informed consent to participate in the project as a
inember of any of the three groups was required before an
initial interview was done. Thus, potential sample members
had to be able to identify a person close to them ("Someone
you see and talk to each day") who could see and hear well
enough to use a sphygmomanometer. Only 3 per cent of the
referred hypertensives outrightly refused to participate, 10
individuals could not designate a "significant other" person,
and approximately the same number were omitted for other
reasons (e.g., did not speak English).
Patients were also asked about plans to move from the
area over the next two years and, in order to control home
visiting mileage costs, were required to live within 30 miles
of the clinic where they were treated. Both small cities and
rural areas were included in this radius. Approximately 15
per cent of the original pool of patients did not meet these
logistical criteria. This left 218 eligible individuals (approxi-
mately 33 per cent of the original number offlagged charts or
52 per cent of those actually seen by HEP staff) enrolled in
the study.
Patients were interviewed by health educators using a
close-ended questionnaire for approximately 45 minutes
during their initial HEP clinic visit. All blood pressure
readings used in these analyses, plus risk factors, co-morbid-
ity, medications, and clinic utilization data, were abstracted
from medical records for every visit patients made to the
clinic in the two years between the pre- and post-interven-
tion interviews.
Patients were randomly allocated to one of three
groups. Group 3 (N = 63) included patients who received
routine medical care; it served as a control group. Patients in
Group 2 (N = 56) received standard medical care plus home
visits over a period of 18 months from either public health
nurses or specially-trained pharmacists. It provided a test of
how effectively home-visiting health practitioners could mo-
tivate and/or reinforce positive health behaviors, including
medication compliance, in non-housebound, non-acutely ill
patients. Group I (N = 99) patients received both standard
medical care and home visits, as well as had "significant
others" whom they chose (usually family members) actively
participate in both home visits and the blood pressure
monitoring process on a daily, or several times weekly,
basis. This strategy, designated "the activated significant
other," was a variant on the self-help concept known as "the
activated patient." It was our expectation that the more
actively involved patients, their families, and health practi-
tioners were in the management of a chronic, asymptomatic
condition such as high blood pressure, the lower patients'
blood pressures were likely to be.
Major Variables
Diastolic blood pressure control status is the dependent
variable in these analyses. The 95 mm Hg cut point is used to
denote uncontrolled blood pressures: in these clinics at the
time of the study (preceding the HDFP findings on the
treatment of mild hypertension)6 this was the most common
measure of blood pressure control used by the 40 or more
physicians treating HEP patients.
The entry blood pressure measure was an average of all
readings from all clinic visits patients made in the year prior
to, and including, the initial HEP interview visit. Subsequent
to entry, blood pressure readings (plus number and type of
anti-hypertensive medications prescribed) were gathered
from clinic charts at two points in time: blood pressure for
the end of the first year is the average of pressures recorded
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TABLE 1-Characteristics of the Study Group at Baseline
Group Group Group
Characteristic 1 2 3 Total
Total # in Group 99 56 63 218
Demographic
Mean age 49 45 47 48
% Married 64 57 57 60
% Female* 53 79 51 59
% Black 77 68 84 77
% with 12 or more Years
Education 28 32 25 28
Clinical
% with Uncontrolled DBP (2 95
mmHg)** 76 59 63 68
Mean Number of Anti-
hypertensive Drugs 1.7 1.5 1.6 1.6
% Obese 32 45 37 37
% with Chronic Co-morbidity 35 27 30 32
% Recently Diagnosed HBP
(- 1 yearago) 14 12 13 13
Provider Setting
% University Hospital* 79 70 57 71
% Community Hospital 21 30 43 29
Psychosocial
Mean Level of Support for
Compliance Behaviors 2.2 2.4 2.5 2.4
Hypertension-specific Distress 4.7 4.7 4.7 4.7
Barriers
% Reporting Difficulty Getting
to Provider 12 25 16 17
% Reporting Trouble Paying for
Drugs and Care 37 32 35 35
*p < .01
**p < .10
at all visits between 7 and 12 months; end of the second year
pressure represents the average of those readings charted
between 19 and 24 months post entry into the study.
The behavioral change strategies described earlier were
the independent variables. A total of 29 nurses and 13
pharmacists served as home visitors. The ratio of nurses to
pharmacists was equivalent for Groups 1 and 2. Although
most of the nurses and pharmacists only participated during
one of the two years, the type of health practitioner re-
mained constant for each patient visited. The duration of and
timing between each visit, plus the specific educational
content and approaches emphasized, were left open to
professional judgment. Patients in Group I had received a
total of 454 visits, with a range from 1 to 12 and a mean of
five visits, when visiting ended after a year and a half. Group
2 patients, with approximately the same range of visits, had
received a total of 311 visits with a mean of six visits at 18
months. Over 60 per cent of the total patient population
visited received four or more visits.
Almost all patients selected a family member as their
"significant other," with 50 per cent choosing a spouse, 25
per cent a son or daughter, and only 7 per cent a non-
TABLE 2-Group 3 versus Group 2: Unadjusted and Adjusted Risk Differences at End of Years
1 and 2
Group 3 Group 2 Unadjusted Adjusted
Per Cent Per Cent Risk Risk
Time Uncontrolled* (N) Uncontrolled* (N) Difference (p) Difference (p)
Baseline 63 (63) 59 (56)
End of First Year 34 (47) 34 (41) 0 (NS) -7** (NS)
End of Second Year 42 (38) 21 (34) 21 (.03) 17*** (.07)
*Diastolic blood pressure - 95 mm Hg.
"Adjusted for blood pressure at entry, gender, number of anti-hypertensive drugs at entry, history of side effects
durng first year, provider setting, time since diagnosis.
***Adjusted for provider setting, number of anti-hypertensive drugs at end of first year, race, education, age,
difficulty paying for care.
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relative. Less than one-fourth of the patients reported at the
end of the two-year visiting period that they had switched
blood pressure monitors from one family member to anoth-
er. Evidence from weekly diaries kept by the patients and
from home visit report forms suggest that, at least by the end
of the first year of the project, a majority of these patients'
"significant others" were still taking and periodically re-
cording blood pressures.
Description of Groups at Baseline
Relevant characteristics of the three groups at baseline
are summarized in Table 1. The sample is predominantly
Black and middle-aged, with group 2 having significantly
more females compared to Groups 1 and 3. Significant
differences were discovered for two other variables. The
first was blood pressure control status; Group 1 started off
with the greatest percentage of subjects with blood pressure
readings above 95 mm Hg. All groups began the study with a
majority of their members having uncontrolled blood pres-
sure despite having been diagnosed for over a year. The only
other significant difference was for provider setting. A
majority of patients in Groups 1 and 2 attended clinics in the
university hospital while Group 3 patients were more evenly
divided between the two hospitals.
The demographic and clinical data were supplemented
by two additional categories of variables. The psychosocial
measures included scores on a three-item index (Cronbach's
a = .61) measuring perceived worry over the possible impact
of hypertension and a four-item index (a = .77) measuring
the amount of support for continued medication and appoint-
ment compliance that patients received from family and
friends. Questions about barriers assessed the affordability
and accessibility of care. Group scores were not significantly
different for any of these measures.
Analysis
The data are analyzed by examining the proportions of
patients with uncontrolled blood pressure in each of the
three pairs of groups (e.g., Group 3 vs Group 2, Group 3 vs
Group 1, etc.) at the two post-baseline points in time. These
proportions may be thought of as group-specific estimates of
the risk of having uncontrolled blood pressure. Risk differ-
ences are then obtained by subtracting the proportion of
patients with uncontrolled blood pressure in the experimen-
tal group from the corresponding proportion in the control
group. These measures (sometimes referred to as attribut-
able risk)25 can be interpreted as the impact that the inter-
vention would have on patients who receive routine medical
care for their hypertension (i.e., the control group). One-
tailed p values based on the Mantel/Haenszel statistic26 are
reported for these risk differences.
In the multivariable analysis, adjusted risk differences
are calculated to assess the intervention effects while con-
trolling for the influence of other factors.* The variables to
*Kleinbaum DG, Kupper LI, Morgenstern H, Logue E: The
control of confounding in epidemiological studies. Paper presented
at American Public Health Association meeting, October 15-19,
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FIGURE 1-Proportion of Patients with Uncontrolled Hypertension
(DBP . 95 mm Hg) at the End of Years One and Two
be included in the multivariable analysis were determined by
a stepwise binary linear regression procedure. Those vari-
able competing to enter the regression models were all the
baseline characteristics (Table 1) plus reports of medication-
induced side effects during the first or second year, a
measure derived from the abstracts of the clinic records.
Because of the restricted sample size in some comparisons
(e.g., Groups 2 and 3 in the second year) only six variables
were allowed to enter each model. Since almost all of the
variance was accounted for by three or four variables, this
decision did not seem to diminish validity. Those variables
selected as control variables for the first and second year
models are listed at the bottom of Tables 2-4; collectively
they explain 21 and 23 per cent of the variability in blood
pressure control at the end of years one and two.
Two final caveats should be noted. First, because of the
limited sample size, the presence of interaction could not be
explored. Secondly, multiple comparisons are made among
the three study groups for the two outcomes; we concur with
Tukey's recommendation for cautious interpretation in such
circumstances and eventual replication of the results.27
Results
As shown in Figure I and Table 2, Group 2 (visited by
health practitioners) and Group 3 (the control group) began
the study with roughly equivalent proportions of individuals
with uncontrolled blood pressure. By the end of the first
year, those proportions were markedly reduced and exactly
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TABLE 3-Group 3 versus Group 1: Unadjusted and Adjusted Risk Differences at End of Years
1 and 2
Group 3 Group 1 Unadjusted Adjusted
Per Cent Per Cent Risk Risk
Time Uncontrolled* (N) Uncontrolled* (N) Difference (p) Difference (p)
Baseline 63 (63) 76 (99)
End of First Year 34 (47) 39 (74) -5 (NS) 3** (NS)
End of Second Year 42 (38) 25 (55) 17 (.05) 15*** (.07)
*Diastolic blood pressure - 95 mm Hg.
"Adjusted for blood pressure at entry, gender, number of anti-hypertensive drugs at entry, history of side effects
during first year, provider setting, time since diagnosis.
***Adjusted for provider setting, number of anti-hypertensive drugs at end of first year, race, education, age,
difficulty paying for care.
equivalent (34 per cent). However, by the end of the second
year, Group 3 had regressed somewhat while Group 2 had
shown continued improvement in blood pressure control (p
= .03). It appears that supplementing routine care with
periodic home visits produced well-controlled blood pres-
sure in an additional 21 per cent (i.e., 42 per cent-21 per
cent) of the patients, cutting in half the proportion who were
not controlled by routine care alone. The adjusted risk
differences convey a similar picture.
The same trend can be seen in Table 3. As with Group 2,
Group 1 continued to improve in the second year and at the
year's end the proportion of Group 3 patients with uncon-
trolled blood pressure exceeded that of Group 1 by 17 per
cent (p = .05). This finding also remained largely unchanged
after adjustment for potential confounding.
From the above descriptions one might expect negligi-
ble differences when the two behavioral change strategies
(family involvement plus home visits, and home visits alone)
are compared with one another. The evidence in Figure 1
and Table 4 shows this to be the case. The unadjusted risk
differences indicate that Group 2 maintained a slight advan-
tage at both points in time. After adjustment Group 1
possessed the advantage in outcome at year one and the
groups were equivalent for year two. The p values for all
these comparisons are not significant. Thus, while each of
the two supportive interventions seem clearly superior to the
control group over time, which of the two is more effective
for reducing the proportion of patients with uncontrolled
blood pressure is less clear.
Discussion
Hypertensive individuals who received home visits by
nurses or pharmacists were more likely to have controlled
diastolic blood pressure than individuals who were given
routine care. The contrast only became apparent in the
second year, suggesting an effect that was delayed as home
visits accumulated over time (Green's "sleeper" effect28)
but that persisted during the six months after all home
visiting had ceased.
The impact on hypertensive individuals who received
home visits and increased attention of family members
taught to monitor patients' blood pressures was similar to
that observed for those receiving home visits alone. These
findings increase our confidence in the assertion of Taylor,
et al, that attentive concern or sympathetic supervision by
influential others results in improvement in both compliance
and blood pressure for hypertensive patients.'4 The absence
of any significant difference between the two interventions is
harder to account for. Although these conclusions cannot be
attributed to confounding, they should still be considered
with caution because of the small sample size and multiple
comparisons.
These results do not lend support to the belief that
involving family members in a structured, routine task as a
means of encouraging patients to continue to perform the
life-long behaviors required of them adds anything over and
above the motivation provided by home visitors. On the
other hand, while active participation of patients and family
TABLE 4-Group 2 versus Group 1: Unadjusted and Adjusted Risk Differences at End of Years
1 and 2
Group 2 Group 1 Unadjusted Adjusted
Per Cent Per Cent Risk Risk
Time Uncontrolled* (N) Uncontrolled* (N) Difference (p) Difference (p)
Baseline 59 (56) 76 (99)
End of First Year 34 (41) 39 (74) -5 (NS) 8** (NS)
End of Second Year 21 (34) 25 (55) -4 (NS) 0*** (NS)
*Diastolic blood pressure 2 95 mm Hg.
"Adjusted for blood pressure at entry, gender, number of anti-hypertensive drugs at entry, history of side effects
during first year, provider setting, time since diagnosis.
'Adjusted for provider setting, number of anti-hypertensive drugs at end of first year, race, education, age,
difficulty paying for care.
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members in chronic self-care would seem preferable, philo-
sophically as well as pragmatically, to providing medical
supervision at home over a period of years, the study design
used in this research did not permit a simple, direct compari-
son of these two concepts; home visitors were viewed as
necessary for originally teaching and intermittently encour-
aging patients and their "significant others" to use the home
blood pressure kits. Indeed, the study's design does not
allow us to tease apart the beneficial effects attributable to
generalized family support from those due specifically to
either the home monitoring procedure itself or the home
visits. Thus, whether family or patient self-monitoring alone
is indeed "worth it" remains to be demonstrated.
Kirscht, et al, found that patients who monitored their
own blood pressures and received support from family
members were no more compliant with their hypertensive
regimens than patients receiving support only.29 Haynes, et
al, found that home blood pressure monitoring was not
effective without health practitioner home visits, and compli-
ance actually fell off after visiting ceased.'5 We would
suggest, along with Haynes et al, that home blood pressure
monitoring, whether done by an "activated" patient or
"significant other" is probably most beneficial as a compli-
ance aid when combined with other methods of behavioral
reinforcement, such as family participation during clinic
visits or occasional phone calls or home visits by health
practitioners.
Several studies have evaluated the effectiveness of
home visits to hypertensive patients expected to follow
medical regimens on a long-term daily basis. At least two
studies have found that home visits by health care practition-
ers have short-term beneficial effects on compliance.20,2'
Our data also suggest that such visits, with or without family
involvement, are effective in controlling blood pressure,
although a significant effect was not observed for the pa-
tients in this study until 12 or more months of visiting had
occurred. Unlike the data reported here, however, Johnson
found that without a conscientious effort by family members
or visitors to provide patients with "support," practitioner
home visits (with or without home monitoring) did not
improve hypertensive patients' compliance. 16 This divergent
finding may be due to the fact that home visiting in the
Johnson study lasted only six months; thus visits may have
been terminated before their benefits were detectable at a
statistically significant level of effective blood pressure con-
trol. Another explanation for the difference between the two
studies may lie in their use of dissimilar outcome measures
(self-reported and pill-count compliance rather than a de-
crease in the level of diastolic blood pressure).
Aside from the cumulative nature or delayed effect issue
of the particular behavioral change strategies examined in
this study, these findings both diverge from and support
those reported previously in other ways. Most, although not
all,'0 researchers have found that social support is positively
associated with compliance behavior.'822 While Levine, et
al, found a significant difference, as we did, between experi-
mental and control groups, their data, unlike ours, suggest
that combining home visits and family support is a more
effective strategy for achieving blood pressure control than
home visits alone.'2 The difference between the two studies
may lie in the fact that their research design called for only a
single, rather than multiple, home visits. Also, as others
have indicated, although it would appear that social support
and practitioner home visits have some effect on blood
pressure control,'4,30 the precise nature and operation of the
effect remain to be investigated more fully.
As with other studies in which a combination of maneu-
vers tested singly as well as in concert are compared, the use
of multiple and multi-dimensional components makes it
almost impossible to determine exactly what it is that works.
However, while there may be a loss of specificity with
regard to the theoretical underpinnings of the intervention's
"mechanism of action," the very "ordinariness" and/or
comprehensive nature of such strategies may result in a gain
in generalizability. Under such circumstances it would seem
that future research could go in one of several directions.
One would be to sub-divide the components of each strategy
and test each separately against the others. A second is to
take the combined set of maneuvers and compare its effec-
tiveness for various types of patients under varying condi-
tions. A third approach would be to compare a program that
contained all the elements in the presumed "mix" of inter-
ventions required for the desired effect with other experi-
mental groups, each of which received the complete program
minus one of the elements being tested.3' The goal of the
second approach would be to determine what groups of
patients under which circumstances would benefit the most
from the combined strategy so it could then be selectively
applied to those for whom it would most likely be successful.
The goal of the third approach would be to determine which
educational component made "the difference" in the total
package.
Several methodologic points should be considered when
interpreting these data. Patients who dropped out of care or
had no appointments during the second half of the year
consequently had no outcome measures for consideration in
the analysis. The extent of such attrition is considerable; the
total number of subjects in the analyses for years one and
two represent 74 and 58 per cent of the baseline sample,
respectively. This can lead to biased results in two ways.
The first is by introducing confounding bias. However, in
most cases the difference between the unadjusted and adjust-
ed risk differences is quite small, indicating little confound-
ing either from baseline differences between the groups or
because of selective attrition.
The second way in which subject attrition can produce
bias is not ameliorated by controlling for confounding. It
occurs when group status (i.e., experimental vs control) is an
effect-modifier for the association of clinic attendance with
outcome32 (i.e., when group status differentially influences
clinic attendance during the study period for subjects with
controlled and uncontrolled blood pressure). During weekly
meetings with project staff, the pharmacists and nurses
indicated that they placed extra emphasis on clinic atten-
dance when encountering a subject with uncontrolled blood
pressure. If actually true, there would have been a more
complete enumeration of subjects with uncontrolled blood
pressure from the experimental groups, and thus an underes-
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timation of the interventions' effects. In a separate paper we
examine the relationship between the intervention, patient
characteristics, and dropping out of treatment.** In that
analysis we found only a weak association between dropping
out of treatment and uncontrolled diastolic blood pressure,
and no evidence of significant effect-modification by either
form of the intervention. While this finding does not confirm
the visitors' impressions, it decreases the likelihood that bias
is present as a result of differential loss to follow-up.
A study such as this raises several other questions. One
concerns the interrelationship between the effects of the
intervention and those of the ongoing medical care (over
which the investigators had little control). In a general sense,
the quality of the interaction between patients and their
physicians might be affected as a result of home visits. The
role such a change might play in controlling experimental
group patients' blood pressure would depend on the nature
of those changes occurring. One might speculate that a
successful behavioral change intervention would partially
preclude more aggressive medical therapy in the experimen-
tal group; in this instance the control group would receive
more intensive medical care. Conversely, if the intervention
had a negative effect one might expect physicians to respond
with more aggressive treatment for those patients in the
experimental group. In both hypothetical circumstances, by
compensating for the medically-disadvantaged group, rou-
tine care would tend to diminish actual differences in con-
trolled blood pressure between the experimental and control
groups.
The changes in one indicator of treatment-the mean
number of prescribed anti-hypertensive medications-sug-
gest that the control group received extra attention over the
period of the study. During this two-year time period, the
mean number of anti-hypertensive medications for both
experimental groups declined slightly, from 1.7 to 1.5 for
Group 1, and from 1.5 to 1.4 for Group 2. In contrast, the
mean number of medications for the control group rose from
1.6 to 1.8. According to the first interpretation offered
above, an efficacious behavioral change-oriented interven-
tion may have enabled physicians to maintain or reduce
these patients' current drug regimens while physicians of
less successful control subjects may have had to resort to
additional medical treatment. Since such an hypothesized
disparity in treatment, if it occurred, would also tend to
decrease differences between the two groups, the credibility
of the positive intervention results is increased.
Finally, it should be remembered that although family
involvement and home practitioner visits have been shown
to have an effect on the control of diastolic blood pressure,
this is not the same as demonstrating that these two interven-
tions improved compliance behaviors. However, it is reas-
suring that others have found blood pressure control status
to be significantly related to self-reports of medication
compliance among hypertensives,'0"2 since there are set-
**Strogatz D, Earp JA: The determinants of dropping out of
care among hypertensives receiving a behavioral intervention (sub-
mitted for publication).
tings in which researchers cannot control either pill-dispens-
ing or pill-counting and thus they must rely on blood
pressure readings as indicators of compliance behavior.
The obvious drawback to the wider use of practitioner
home visits, with or without family involvement, is the issue
of costliness. Whether the number or duration of, or spacing
between, visits could be modified, or the level of training or
type of visitor could be altered, in order to reduce costs
without diluting the effects remains to be investigated.
Indeed, whether phone calls, post cards, or special clinic
sessions with non-physician health professionals inter-
spersed with home visits might be just as effective in
problem-solving or providing supervision, motivation, or
encouragement also might be considered. There is some
research, apart from the hypertension literature, to suggest
that home visiting may reach a "point of diminishing re-
turns" after as short a period as one year.3' If such were the
case with hypertensive patients, it may be more cost effec-
tive for visitors to see more patients fewer times than fewer
patients more often. The effective involvement of family
members might, under these circumstances, have a bigger
pay-off in the long run.
In attempting to understand the absence of a difference
between the two experimental groups, two other points
might be noted. On occasion, the issue of negative effects as
a result of involving family members in patients' medical
regimens has been raised. One source of such a negative
effect might be the heightened potential for family conflict
and any reactive patient behaviors induced as a result of the
required constant monitoring. A second issue is whether
families, unless closely supervised, might not occasionally
give false or contradictory information to patients that might
actually be detrimental to their achieving controlled blood
pressure. The field reports of the 42 home visitors, as well as
the data reported here, would suggest otherwise; i.e., that
family involvement, at least when structured around a
specific task such as blood pressure monitoring or meeting
periodically at home with visiting nurses or pharmacists,
does not appear to have a negative effect on blood pressure
control.
Secondly, it is not known how "pure" the home visiting
intervention alone was; i.e., whether some family members
participated during those visits and whatever knowledge or
motivation they gained as a result of sharing these visits with
the patients had a positive effect on patients' adherence to
medical regimens between visits. Indeed, visitors' field
notes often referred to the presence of family members
during visits, as well as to calls to them by spouses, children,
or parents of patients. In essence this would mean that the
family support component specifically built into Group l's
protocol may have been there, in an informal sense, for
Group 2 as well. Thus, while no difference between Groups 1
and 2 was observed, this finding may not be solely attribut-
able to the content or meaning of the visits which both
groups received. Rather, there may be a greater commitment
to, or level of awareness about, compliance stimulated in
patients' families as a result of participating in the visits.
Finally, it would be erroneous to conclude from these data
that it is the "professional" aspect of the home visits that
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makes the difference. It may simply be a matter of intensive
supervision and monitored reinforcement, whether carried
out by family, practitioner, or community worker, at home
or in clinic, but done consistently, predictably, and over
time. The challenge lies in how to duplicate the intervention
described here most cost-effectively. The same or better
results might be achieved by improving institutional care.
However, simply spending extra time with families during
clinic visits may prove to be less effective in fostering family
participation than are interactions in patients' homes. These
alternatives remain to be tested before clinic care is restruc-
tured.
Since non-compliance is not a single event but, instead,
a complex behavioral phenomenon set in a social, as well as
clinical, context (and thus affected by individual differences
in attitudes, abilities, and familial circumstances) it would
seem that a combination of strategies, rather than a single
panacea, is called for in dealing with it. No one specific,
universally effective, one-shot intervention should be ex-
pected to produce lasting effects. Instead, periodically rein-
forced, problem-specific yet comprehensive strategies selec-
tively applied to individual groups of patients should contin-
ue to be developed and evaluated.
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Special APHA Service Booths to Assist
Convention Registrants in Montreal
Plans for the American Public Health Association's 110th Annual Meeting, to be held November
14-18 in Montreal, are in the final stages and the Association's Convention Department has made a
special effort to anticipate any problems that meeting registrants might encounter upon their arrival in
Canada.
Special APHA Service Booths will be conveniently located at both the Dorval Airport, near the
Canadian Customs area, and at the Place Bonaventure Exhibition Hall, in the Meeting Registration
Area, to assist travelers with last-minute problems and to answer inquiries. Representatives from the
Montreal Housing Bureau, Budget-Rent-A-Car, Washington's World of Travel, and Receptour will be
on hand at the service booth at the airport from Friday through Monday, and at the Bonaventure
throughout the meeting.
Montreal Housing Bureau representatives at the service booths will have a direct line to their
office to assist those persons who have not received their hotel confirmations by mail before leaving the
United States. Or registrants may prefer to call the Housing Bureau (514/871-1129) before leaving the
States. The service booth representative will also know what rooms are still available at the various
hotels, and will make reservations for those individuals who need that service.
Budget-Rent-A-Car will offer discount rates on car rentals for any APHA meeting registrant.
Persons who register in advance for the convention will receive their badges in October, and the badge
will serve as documentation for the discount car rental rates.
Washington's World of Travel-APHA's official travel agency for the Montreal meeting-will
assist on-site with airline and train travel ticketing and information. Prior to the meeting, inquiries
should be directed to WWT's Washington, DC office, telephope 202/872-8777. WWT has also arranged
a nationwide toll free number with Eastern Airlines: 800/327-1295. In Florida, call 800/432-1217.
Receptours of Montreal will handle all arrangements and inquiries related to trips and special tours
in and around Montreal and Quebec, as well as ground transportation from the airport to downtown
hotels. They will also provide information about restaurants in the Montreal area, and make
reservations at the restaurants. The contact person at Receptours is Harry A. Goetschi, telephone 514/
874-9637.
The hours of operation for the various service booths are:
Montreal-Dorval Airport
Friday, November 12-6:00 pm-midnight
Saturday-Monday, November 13-15-8:00 am-midnight
Place Bonaventure Exhibition Hall
Saturday, November 13-1:00 pm-5:00 pm
Sunday, November 14-9:00 am-5:00 pm
Monday-Wednesday, November 15-17-8:00 am-5:00 pm
Hotel Bonaventure
(Foyer, Montreal Ballroom)
Thursday, November 18-8:00 am-6:00 pm
Friday, November 19-8:00 am-3:00 pm
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